• Home
  • >>>>>>>>>>>>> 2026 & BEYOND MASTER PLAN >>>>>>>>>>>>>>>>
  • Virtual Data Room (VDR) for Strategic Customized Slide Decks
  • TRAINABLE DATA ASSETS IN CORPORATE LEGACY & ORGANIZATION’s STRATEGIC MEMORY (2012 – 2025)
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • Founder’s Vision
  • Portfolio of IP Assets
  • Knowledge PORTALS System (KPS)
  • 1.0 LPBI – 2012-2020 VISTA
  • LPBI Group’s History
  • 2.0 LPBI – 2021-2025 VISION
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder’s Bio
  • Funding, Deals & Partnerships
  • 1.0 LPBI Group News
  • 1.0 LPBI CALENDAR
  • 2.0 LPBI Group News
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2021 Summer Internship Portal
  • 2021-2025 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • Blockchain Transactions Network Ecosystem
  • 1.0 LPBI Brochure
  • 2.0 LPBI Brochure
  • 2.0 LPBI – Calendar of Zooms
  • Coronavirus, SARS-CoV-2 Portal
  • LPBI India
  • SOP Web STAT
  • Synthetic Biology in Drug Discovery
  • Certificate One Year
  • NFT: Redefined Format of IP Assets
  • Audio English-Spanish: BioMed e-Series
  • Five Bilingual BioMed e-Series
  • Press Releases
  • Intangibles CIM
  • BioMed Audio Podcast Library @LPBI Group
  • Medical School Education: Use of LPBI Group’s Contents
  • ChatGPT + Wolfram PlugIn
  • Medicine with GPT-4 & ChatGPT
  • AGI, generativeAI, Grok, DeepSeek & Expert Models in Healthcare
  • Multimodal Healthcare Foundation Model
  • Cell Therapy in Regenerative Medicine, 2026 and Beyond
  • Contact Us

Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA

Healthcare analytics, AI solutions for biological big data, providing an AI platform for the biotech, life sciences, medical and pharmaceutical industries, as well as for related technological approaches, i.e., curation and text analysis with machine learning and other activities related to AI applications to these industries.

Feeds:
Posts
Comments

Amandeep Kaur, BSc., MSc. – Research Associate 3, Medical Text Analysis and Synthetic Biology

Amandeep Kaur, BSc., MSc. – Research Associate 3, Medical Text Analysis and Synthetic Biology

https://pharmaceuticalintelligence.com/contributors-biographies/associates/amandeep-kaur-bsc-msc-9exp-5-2021-research-associate-2-medical-text-analysis-and-it-infrastructure-python-coder/

1. Publications on Pharmaceuticalintelligence.com

DateArticle NameURL  
7 August 2021Novartis uses a ‘dimmer switch’ medication to fine-tune gene therapy candidateshttps://pharmaceuticalintelligence.com/2021/08/07/novartis-uses-a-dimmer-switch-medication-to-fine-tune-gene-therapy-candidates/
7 June 2021 Emergence of a new SARS-CoV-2 variant from GR clade with a novel S glycoprotein mutation V1230L in West Bengal, India https://pharmaceuticalintelligence.com/2021/06/07/emergence-of-a-new-sars-cov-2-variant-from-gr-clade-with-a-novel-s-glycoprotein-mutation-v1230l-in-west-bengal-india/
29 May 2021Developing Machine Learning Models for Prediction of Onset of Type-2 Diabeteshttps://pharmaceuticalintelligence.com/2021/05/29/developing-machine-learning-models-for-prediction-of-onset-of-type-2-diabetes/
25 May 2021C.D.C. Reviewing Cases of Heart Problem in Youngsters After Getting Vaccinatedhttps://pharmaceuticalintelligence.com/2021/05/25/c-d-c-reviewing-cases-of-heart-problem-in-youngsters-after-getting-vaccinated/
4 May 2021Thriving Vaccines and Research: Weizmann Institute Coronavirus Research Developmenthttps://pharmaceuticalintelligence.com/2021/05/04/thriving-vaccines-and-research-weizmann-coronavirus-research-development/
19 April 2021Identification of Novel genes in human that fight COVID-19 infectionhttps://pharmaceuticalintelligence.com/2021/04/19/identification-of-novel-genes-in-human-that-fight-covid-19-infection/
13 April 2021Fighting Chaos with Care, community trust, engagement must be cornerstones of pandemic responsehttps://pharmaceuticalintelligence.com/2021/04/13/fighting-chaos-with-care/
21 March 2021Two brothers with MEPAN Syndrome: A Rare Genetic Disorderhttps://pharmaceuticalintelligence.com/2021/03/21/two-brothers-with-mepan-syndrome-a-rare-genetic-disorder/
11 Jan 2021 Dysregulation of ncRNAs in association with Neurodegenerative Disorders https://pharmaceuticalintelligence.com/2021/01/11/dysregulation-of-ncrnas-in-association-with-neurodegenerative-disorders/

2. Progress on Text Analysis

6 June 2021

LPBI Phase 2: Proof of Concept – Genomics Volume 1- Chapter 2 Completion

Dropbox– Includes MS Word Files, Text Files, Biological Images File, WORD CLOUDs, Bar Graph and PPT

URL: https://www.dropbox.com/home/LPBI%20Group/Phase%202%3A%20Proof%20of%20Concept/Amandeep/Genomics%2C%20Vol1/Chapter%202

WORD CLOUDs Uploaded in Articles of Chapter 2

Article 2.1- https://pharmaceuticalintelligence.com/2013/02/11/2013-genomics-the-era-beyond-the-sequencing-human-genome-francis-collins-craig-venter-eric-lander-et-al/

Article 2.2- https://pharmaceuticalintelligence.com/2013/02/15/dna-structure-and-oligonucleotides/

Article 2.3- https://pharmaceuticalintelligence.com/2013/02/03/genome-wide-detection-of-single-nucleotide-and-copy-number-variation-of-a-single-human-cell/

Article 2.4- https://pharmaceuticalintelligence.com/2013/02/14/genomics-and-evolution/

Article 2.5- https://pharmaceuticalintelligence.com/2013/03/16/protein-folding-simulation-stanfords-framework-for-testing-and-predicting-evolutionary-outcomes-in-living-organisms/

Article 2.6- https://pharmaceuticalintelligence.com/2013/05/15/the-binding-of-oligonucleotides-in-dna-and-3-d-lattice-structures/

Article 2.7- https://pharmaceuticalintelligence.com/2013/05/15/finding-the-genetic-links-in-common-disease-caveats-of-whole-genome-sequencing-studies/

23 May 2021

LPBI Phase 2: Proof of Concept – Genomics Volume 1- Chapter 1 Completion

Dropbox– Includes MS Word Files, Text Files, Biological Images File, WORD CLOUDs, Bar Graph and PPT

URL: https://www.dropbox.com/home/LPBI%20Group/Phase%202%3A%20Proof%20of%20Concept/Amandeep/Genomics%2C%20Vol1/Chapter%201

WORD CLOUDs Uploaded in Articles of Chapter 1

Article 1.1- https://pharmaceuticalintelligence.com/2013/02/08/the-initiation-and-growth-of-molecular-biology-and-genomics/

Article 1.2- https://pharmaceuticalintelligence.com/2013/02/12/cracking-the-code-of-human-life-milestones-along-the-way/

Article 1.3- https://pharmaceuticalintelligence.com/2012/08/27/dna-the-next-generation-storage-media-for-digital-information/

Article 1.4- https://pharmaceuticalintelligence.com/2013/02/14/cracking-the-code-of-human-life-recent-advances-in-genomic-analysis-and-disease/

Article 1.5- https://pharmaceuticalintelligence.com/2012/10/22/advances-in-separations-technology-for-the-omics-and-clarification-of-therapeutic-targets/

Article 1.6- https://pharmaceuticalintelligence.com/2012/08/22/genomic-analysis-fluidigm-technology-in-the-life-science-and-agricultural-biotechnology/

17 May 2021

LPBI Phase 2: Proof of Concept – Genomics Volume 1 – Chapter 21 Completion

Dropbox- Includes MS Word Files, Text Files, Biological Images File, WORD CLOUDs, Bar Graph and PPT

URL: https://www.dropbox.com/home/LPBI%20Group/Phase%202%3A%20Proof%20of%20Concept/Amandeep/Genomics%2C%20Vol1/Chapter%2021

WORD CLOUDs Uploaded in Articles of Chapter 21:

Article 21.1 Introducing CRISPR/Cas9 Gene Editing Technology – Works by Jennifer A. Doudna

Article 21.1.2- https://pharmaceuticalintelligence.com/2014/03/25/evaluate-your-cas9-gene-editing-vectors-crisprcas-mediated-genome-engineering-is-your-crispr-grna-optimized-for-your-cell-lines/
Article 21.1.3- https://pharmaceuticalintelligence.com/2014/06/13/215-245-6132014-jennifer-doudna-the-biology-of-crisprs-from-genome-defense-to-genetic-engineering/
Article 21.1.4- https://pharmaceuticalintelligence.com/2014/06/16/prediction-of-the-winner-rna-technology-the-frontier-of-science-on-rna-biology-cancer-and-therapeutics-the-start-up-landscape-in-boston/

Article 21.2 CRISPR in Other Labs
Article 21.2.1- https://pharmaceuticalintelligence.com/2014/04/21/crispr-mit-genome-surgery/
Article 21.2.3- https://pharmaceuticalintelligence.com/2014/10/29/new-frontiers-in-gene-editing-transitioning-from-the-lab-to-the-clinic-february-19-20-2015-the-intercontinental-san-francisco-san-francisco-ca/
Article 21.2.4- https://pharmaceuticalintelligence.com/2014/03/27/gene-therapy-and-the-genetic-study-of-disease-berkeley-and-ucsf-new-dna-editing-technology-spawns-bold-uc-initiative-as-crispr-goes-global/

Article 21.3 Patents Awarded and Pending for CRISPR
Article 21.3.1-  https://pharmaceuticalintelligence.com/2014/12/05/litigation-on-the-way-broad-institute-gets-patent-on-revolutionary-gene-editing-method/
Article 21.3.2- https://pharmaceuticalintelligence.com/2014/12/05/the-patents-for-crispr-the-dna-editing-technology-as-the-biggest-biotech-discovery-of-the-century/

Article 21.4 CRISPR/Cas9 Applications
Article 21.4.2- https://pharmaceuticalintelligence.com/2014/11/04/crispr-applications-for-autoimmune-diseases-ucsf/
Article 21.4.4- https://pharmaceuticalintelligence.com/2015/08/30/delineating-a-role-for-crispr-cas9-in-pharmaceutical-targeting/
Article 21.4.5- https://pharmaceuticalintelligence.com/2015/09/01/where-is-the-most-promising-avenue-to-success-in-pharmaceuticals-with-crispr-cas9/
Article 21.4.6- https://pharmaceuticalintelligence.com/2015/08/30/level-of-comfort-with-making-changes-to-the-dna-of-an-organism/

Article 21.4.7- https://pharmaceuticalintelligence.com/2015/09/01/who-will-be-the-the-first-to-ipo-novartis-bought-in-to-intellia-uc-berkeley-as-well-as-caribou-vs-editas-mit/

Article 21.4.8- https://pharmaceuticalintelligence.com/2015/09/02/crisprcas9-finds-its-way-as-an-important-tool-for-drug-discovery-development/

28 March 2021

Streamlined the WORKFLOW for MEDICAL TEXT ANALYSIS based on INSTRUCTIONS given by MADISON and MODIFIED by Aviva

The workflow is as Follows:

1.  One MS Word file for All Articles in a chapter – Chapter’s subject CONTEXT as UNIT CASE for Text Analysis by NLP

2.  One Text file for All Articles in a chapter – to be used for Wolfram NLP

3.  One MS Word File Containing All the Biological Images with Article Name, Author, URL of All Articles in a chapter – to be use for uploading images to the Gallery of the NEW WEBSITE for 2.0 LPBI [under construction]

4.  One MS Word file per Article  – to be INDEXED for Blockchain Transactions Network

5.  One Text file per Article – to be used for 2, above

6.  One WordCloud per Article – Test Analysis visual #1

7.  One Bar Diagram from Above option 1 (means All Articles) – Test Analysis visual #2

7.1  One Bar Diagram produced from 2, above – Text Analysis visual # 2.1 – Word frequency for Subject Context of the Chapter 

8.  One Wolfram Hyper-graph from Above option 1 (means All Articles) – Test Analysis visual #3

9.  One Tree Diagram from Above option 1 (means All Articles) – Test Analysis visual #4

10.  One PowerPoint Presentation PER CHAPTER containing WordClouds, bar diagrams, hyper-graphs, tree diagrams of i.e., Genomic Vol 1 (means All chapters) – Test Analysis visual #5

11.  Domain Knowledge Expert Interpretations in English Text for 8, above – Test Analysis Interpretation of Hyper-graph in English Text File #6 [Place holder for Dr. Williams]

12.  Domain Knowledge Expert Interpretations in English Text for 9, above – Test Analysis Interpretation of Tree Diagram in English Text File #7 [Place holder for Dr. Williams]

13.  Translation of 11, above [Interpretation of Hyper-graph] into three languages each – Test Analysis Translation Texts

#8, #9, #10 [three place holders]

14.  Translation of 12, above [Interpretation of Tree diagram] into three languages each – Test Analysis Translation Texts #11, #12, #13 [three place holders]

Share this:

  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Facebook (Opens in new window) Facebook
  • Print (Opens in new window) Print
  • Email a link to a friend (Opens in new window) Email

Like this:

Like Loading…

  • Follow Blog via Email

    Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 2,107 other subscribers
  • Recent Posts

    • Novartis and Bristol Myers Squibb halt CAR-T trial for autoimmune diseases over patient deaths: a potential issue with cell-based manufacturing September 15, 2026
    • FDA Contemplates Changes in Trial Design, Drug Development, and Use of AI in Clinical Trials September 15, 2026
    • FDA Moves Forward With Its Guidance Framework for Rare Disease Trials: 2026 August 3, 2026
    • Artificial Intelligence TRANSFORMS Medicine, Biotech and Healthcare, How? August 3, 2026
    • In Memoriam: Nobel Laureate J. Michael Bishop for discovery of Retroviral Oncogenes July 31, 2026
    • Companies Actively Engaging Artificial Intellegence for Drug Design: 2026 July 31, 2026
    • AI-Native Drug Discovery Landscape 2026 – How LPBI Group Differentiates in the New Era of Foundation Models July 19, 2026
    • In Memoriam: In Remembrance of Cancer Researchers who passed in 2026 July 13, 2026
    • Urgent Request for Action on Proposed Rule Affecting Federal Funding Grant Review July 7, 2026
    • 2026 Tang Prize in Biopharmaceutical Science Awarded to Three Pioneers of Cellular Immunotherapy Revolutionizing Treatments for Blood Cancers and Solid Tumors July 5, 2026
  • Archives

  • Categories

  • Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • 1 2012pharmaceutical
    • 1 sjwilliamspa

Powered by WordPress.com.

WPThemes.


%d